Others make a more nuanced argument, that these drugs dont address the drivers of obesity, such as the barriers in access to nutritious, fresh foods
Recalls & Warnings September 23, 2014 Maker of Joint and Weight Products Warned for Hidden Drugs, Manufacturing Violations On September 15, 2014, the FDA issued a warning letter to West Coast Laboratories, Inc., because the company's joint health supplements, Super ArthGold and Pro ArthMax, were found to contain hidden drugs
The subsequent phase 3 trial of tirzepatide demonstrated more effective reductions in the glycated hemoglobin levels and body weight, along with greater overall improvements in the lipid profile compared to semaglutide in patients with T2DM, elevating incretin therapeutic agents to a new level (112)
A cheaper product that doesn't work isn't saving you money
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review
B., Kwak, S., Cheon, S